Compare AMRX & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | TFX |
|---|---|---|
| Founded | 2002 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.8B |
| IPO Year | 2018 | 1994 |
| Metric | AMRX | TFX |
|---|---|---|
| Price | $19.82 | $122.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $15.60 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 2.0M | 624.7K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | 0.37 | ★ 2.08 |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $4.48 | $15.97 |
| Revenue Next Year | $7.13 | $5.15 |
| P/E Ratio | ★ $53.53 | $57.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.56 | $100.18 |
| 52 Week High | $21.18 | $145.00 |
| Indicator | AMRX | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 64.19 | 32.35 |
| Support Level | $16.59 | $119.69 |
| Resistance Level | N/A | $123.47 |
| Average True Range (ATR) | 0.87 | 3.77 |
| MACD | 0.26 | -1.19 |
| Stochastic Oscillator | 70.42 | 21.01 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.